CACCURI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 4.807
EU - Europa 1.990
AS - Asia 1.308
AF - Africa 15
SA - Sud America 13
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.151
Nazione #
US - Stati Uniti d'America 4.787
IT - Italia 507
CN - Cina 488
UA - Ucraina 381
SG - Singapore 334
HK - Hong Kong 308
PL - Polonia 239
DE - Germania 221
FI - Finlandia 172
TR - Turchia 110
RU - Federazione Russa 103
GB - Regno Unito 96
IE - Irlanda 91
FR - Francia 69
BE - Belgio 28
CZ - Repubblica Ceca 21
SE - Svezia 21
IN - India 20
CA - Canada 18
VN - Vietnam 13
AU - Australia 11
ID - Indonesia 8
AT - Austria 7
ET - Etiopia 7
EU - Europa 6
AR - Argentina 4
NL - Olanda 4
AZ - Azerbaigian 3
EE - Estonia 3
IR - Iran 3
KG - Kirghizistan 3
KR - Corea 3
LT - Lituania 3
MU - Mauritius 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
BR - Brasile 2
CH - Svizzera 2
CL - Cile 2
CM - Camerun 2
CO - Colombia 2
ES - Italia 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
PE - Perù 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
RO - Romania 1
SL - Sierra Leone 1
ZA - Sudafrica 1
Totale 8.151
Città #
Fairfield 717
Woodbridge 504
Ashburn 359
Seattle 344
Houston 308
Hong Kong 307
Cambridge 298
Jacksonville 288
Singapore 272
Ann Arbor 270
Chandler 255
Warsaw 238
Wilmington 238
Brescia 197
Princeton 167
Helsinki 137
New York 126
Beijing 116
Istanbul 99
Dublin 91
Dearborn 62
Nanjing 61
Shanghai 60
Moscow 36
Munich 34
San Diego 34
Des Moines 32
Hebei 31
Nanchang 29
Brussels 27
Los Angeles 27
Boardman 26
Changsha 23
Jinan 23
Brno 20
Shenyang 20
London 19
Milan 17
Tianjin 16
Jiaxing 15
San Francisco 13
Dong Ket 12
Nuremberg 12
Romola 11
Rome 10
Toronto 10
Kocaeli 9
Kunming 9
Verona 9
Falkenstein 8
Haikou 8
Kilburn 8
Taizhou 8
Zhengzhou 8
Auburn Hills 7
Castiglione Delle Stiviere 7
Falls Church 7
Ningbo 7
Ottawa 7
Redwood City 7
Jakarta 6
Norwalk 6
Porto 6
Vienna 6
Guangzhou 5
Gunzenhausen 5
Hangzhou 5
Hefei 5
Lanzhou 5
Montelabbate 5
Turin 5
Espoo 4
Lancaster 4
Lappeenranta 4
New Bedfont 4
Orange 4
Pune 4
As 3
Baku 3
Bergamo 3
Bishkek 3
Bratislava 3
Chicago 3
Chongqing 3
Detroit 3
Florence 3
Glasgow 3
Melbourne 3
Redmond 3
Rende 3
Santa Clara 3
Spoltore 3
Sydney 3
Tallinn 3
Taranto 3
Udine 3
Villanuova Sul Clisi 3
Almaty 2
Amman 2
Ardabil 2
Totale 6.269
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 292
Detection and molecular characterization of enteric viruses in children with acute gastroenteritis in Northern Italy 218
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 176
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 167
Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis. 153
Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor. 149
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 142
In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae. 140
A cluster of invasive listeriosis in Brescia, Italy. 139
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae among high-school participants using the Versant CT/GC DNA 1.0 assay (kinetic PCR). 136
A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17 132
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting. 131
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 131
The immunomodulatory molecule pidotimod induces the expression of the nod-like receptor nlrp12 and attenuates tlr-induced inflammation. 130
Detection of HIV-1 matrix protein p17 quasispecies variants in plasma of chronic HIV-1-infected patients by ultra-deep pyrosequencing. 129
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition 128
Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17. 125
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 123
Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth. 120
Myroides odoratimimus urinary tract infection in an immunocompromised patient: An emerging multidrug-resistant micro-organism 119
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 117
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 115
Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones 115
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 115
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 114
HIV-1 matrix protein p17 and its receptors. 113
Human lung epithelial cells support human metapneumovirus persistence by overcoming apoptosis. 112
Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia. 112
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 111
Detection of KI WU and Merkel cell polyomavirus in respiratory tract of cystic fibrosis patients. 110
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 110
HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis. 110
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 107
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders 106
For timing of HAART is less more? CD4+/CD8+ ratio and CD4+ percentage as surrogate markers for more complex immunological features. 105
null 104
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. 103
The U94 Gene of Human Herpesvirus 6: A Narrative Review of Its Role and Potential Functions 102
HIV-1 matrix protein p17: A candidate antigen for therapeutic vaccines against AIDS. 102
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient 100
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 99
Extensively drug-resistant Acinetobacter baumannii isolated from intensive care units in Northern Italy: a genomic approach to characterize new sequence types. 99
p17 from HIV induces brain endothelial cell angiogenesis through EGFR-1-mediated cell signalling activation 98
Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells 98
Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy. 97
Inhibition of dna repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 u94 96
HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness 94
Regulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120 90
Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants 90
Clinical course of chronic hepatitis B patients receiving nucleos(t)ide analogues after virological breakthrough during monotherapy with lamivudine. 89
Erratum for Piccinelli et al., "In Vitro Activity of Solithromycin against Erythromycin-Resistant Streptococcus agalactiae" 88
Fulminant septic shock caused by Capnocytophaga canimorsus in Italy: Case report 88
Multicenter Evaluation of the Anyplex™ Plus MTB/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-resistant Isolates in Pulmonary and Extrapulmonary Specimens 87
Programmable Nucleic Acid Nanoswitches for the Rapid, Single-Step Detection of Antibodies in Bodily Fluids 86
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 85
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 84
Human Herpesvirus 6A and 6B inhibit in vitro angiogenesis by induction of Human Leukocyte Antigen G 82
The synthetic dipeptide pidotimod shows a chemokine-like activity through cxc chemokine receptor 3 (Cxcr3) 73
Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal study 73
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 73
In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma 71
HIV-1 infection, microenvironment and endothelial cell dysfunction. 66
A topical desiccant agent in association with ultrasonic debridement in the initial treatment of chronic periodontitis: a clinical and microbiological study 63
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro” 63
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 59
Role of autophagy in von willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the hiv-1 matrix protein p17 58
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 58
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 57
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 53
Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy 51
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 48
Human Metapneumovirus Establishes Persistent Infection in Lung Microvascular Endothelial Cells and Primes a Th2-Skewed Immune Response 45
Role of Q675H mutation in improving SARS-CoV-2 spike interaction with the furin binding pocket 45
A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine 40
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants 39
The first Italian outbreak of SARS-CoV-2 B.1.1.7 lineage in Corzano, Lombardy 38
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort 36
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 36
The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier 35
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 34
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 33
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants 30
Genomic surveillance of SARS-CoV-2 in patients presenting neurological manifestations 30
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 29
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies 28
Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of sars-cov-2 infectivity 28
Viral proteins as emerging cancer therapeutics 27
Traceability of SARS-CoV-2 transmission through quasispecies analysis 25
Detection of SARS-CoV-2 Alpha variant in a severely immunocompromised HIV-1-infected patient in the omicron era 23
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 23
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 23
Covid-19 ocular prophylaxis: The potential role of ozonated-oils in liposome eyedrop gel 21
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 20
Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion 19
Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host 19
SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight 18
A Rare Case of Multidrug-resistant Leclercia adecarboxylata Catheter-related Bloodstream Infection and an Updated Brief Literature Review 17
Virucidal efficacy of a novel silver-based disinfectant against SARS-CoV-2 Omicron BA.5 16
A Rare Case of Multidrug-resistant Leclercia adecarboxylata Catheter-related Bloodstream Infection and an Updated Brief Literature Review 16
Transparent Polymeric Formulations Effective against SARS-CoV-2 Infection 15
Totale 8.387
Categoria #
all - tutte 48.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020809 0 0 0 0 0 0 0 206 142 261 86 114
2020/20211.622 17 240 108 153 48 132 155 238 123 192 147 69
2021/2022845 71 129 9 47 17 34 45 83 32 94 63 221
2022/2023839 121 11 28 54 77 199 4 107 142 2 52 42
2023/2024895 61 18 75 65 46 141 50 43 184 26 46 140
2024/2025995 32 14 22 284 156 195 207 85 0 0 0 0
Totale 8.447